These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 6735021

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Electrophysiological effects of intravenous and oral propafenone in patients with supraventricular paroxysmal tachycardias: correlation with drug blood levels].
    Moya A, Cinca J, Arboix M, Rius J.
    Rev Esp Cardiol; 1985; 38(3):198-202. PubMed ID: 4012004
    [No Abstract] [Full Text] [Related]

  • 25. Propafenone disposition kinetics in cardiac arrhythmia.
    Connolly S, Lebsack C, Winkle RA, Harrison DC, Kates RE.
    Clin Pharmacol Ther; 1984 Aug; 36(2):163-8. PubMed ID: 6744775
    [Abstract] [Full Text] [Related]

  • 26. Pharmacokinetics of intravenous propafenone in patients with episodes of paroxysmal supraventricular tachycardia.
    Arboix M, Puigdemont A, Moya A, Cinca J.
    Methods Find Exp Clin Pharmacol; 1985 Aug; 7(8):435-8. PubMed ID: 4079594
    [Abstract] [Full Text] [Related]

  • 27. [Pharmacokinetics of anti-arrhythmics. 2. Clinical applications].
    Lévy RH, Lévy S, Bricaud H.
    Arch Mal Coeur Vaiss; 1980 Oct; 73(10):1229-35. PubMed ID: 6778416
    [Abstract] [Full Text] [Related]

  • 28. The myocardial levels of the antiarrhythmic drugs: clinical relevance.
    Ferrari M, Padrini R, Piovan D, Bova S, Moretto R, Cargnelli G.
    G Ital Cardiol; 1986 Aug; 16(8):660-2. PubMed ID: 3792731
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Antiarrhythmic efficacy of propafenone: evaluation of effective plasma levels following single and multiple doses.
    Frabetti L, Marchesini B, Capucci A, Cavallini C, Gubelli S, Ambrosioni E, Magnani B.
    Eur J Clin Pharmacol; 1986 Aug; 30(6):665-71. PubMed ID: 2429844
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Pharmacokinetics of anti-arrhythmics. 1. Fundamental principles].
    Lévy RH.
    Arch Mal Coeur Vaiss; 1980 Oct; 73(10):1223-8. PubMed ID: 6778415
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Ibutilide added to propafenone for the conversion of atrial fibrillation and atrial flutter.
    Chiladakis JA, Kalogeropoulos A, Patsouras N, Manolis AS.
    J Am Coll Cardiol; 2004 Aug 18; 44(4):859-63. PubMed ID: 15312872
    [Abstract] [Full Text] [Related]

  • 36. Metabolite cumulation during chronic propafenone dosing in arrhythmia.
    Kates RE, Yee YG, Winkle RA.
    Clin Pharmacol Ther; 1985 Jun 18; 37(6):610-4. PubMed ID: 4006362
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Outpatient treatment of recurrent atrial fibrillation with the "pill-in-the-pocket" approach: practical aspects].
    Alboni P, Botto GL, Baldi N.
    Ital Heart J Suppl; 2005 Jun 18; 6(6):335-40. PubMed ID: 16013424
    [Abstract] [Full Text] [Related]

  • 39. [Experimental characterization of propafenone. Hemodynamic effects].
    Botti G, Aurier E, Finardi A.
    G Ital Cardiol; 1984 May 18; 14(5):373-6. PubMed ID: 6468819
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.